Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 3, 2026 · Other material event · Item 3.03 · Charter amendment · +1 more
Silo Pharma, Inc.
8
Other material event
Jun 3, 2026
| Form type | Current report (Form 8-K) |
| Event summary | Other material event · Item 3.03 · Charter amendment · +1 more |
| Primary topic | Other material event |
| About this form | Public companies file this within four business days when something important happens that investors should know about, before the next quarterly report. |
| Why this was filed | Silo Pharma, Inc. filed this to release information to investors under Regulation FD, usually a press release, conference presentation, or other event the company considers important. Washington Boulevard Sarasota , FL 34236 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: ( 718 ) 400-9031 N/A (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant… |
| Labor angle | Watch for Item 2.05 (restructuring or severance), Item 5.02 (leadership changes), and Item 1.01 (major contracts that can precede workforce shifts). |
| Period of report | Jun 1, 2026 |
| Accession number | 0001213900-26-064804 |
| Reported items | Item 3.03, Amended articles of incorporation or bylaws, Other events the company considers material, Financial statements and exhibits See Analysis tab for workforce implications |
